Get the Stockscreener App
32.61
3.81%
-1.29
After Hours:
32.00
-0.61
-1.87%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $32.61, with a volume of 607.10K.
It is down -3.81% in the last 24 hours and up +3.36% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$33.90
Open:
$34.52
24h Volume:
607.10K
Relative Volume:
0.67
Market Cap:
$1.64B
Revenue:
$203.27M
Net Income/Loss:
$-4.66M
P/E Ratio:
-326.10
EPS:
-0.1
Net Cash Flow:
$3.47M
1W Performance:
-3.81%
1M Performance:
+3.36%
6M Performance:
+130.30%
1Y Performance:
+83.31%
1-Day Range:
$32.30
$34.58
1-Week Range:
$30.98
$35.65
52-Week Range:
$9.215
$36.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
32.61 | 1.70B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Liquidity Mapping Around (AXGN) Price Events - Stock Traders Daily
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - The Manila Times
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewswire Inc.
Breakeven Is Near for Axogen, Inc. (NASDAQ:AXGN) - Yahoo Finance
Aug Levels: What is the implied volatility of ORKAJuly 2025 EndofMonth & Weekly Top Stock Performers List - baoquankhu1.vn
Volatility Watch: Can Mercantile Bank Corporation stock outperform in a bear market2025 Year in Review & Verified Technical Signals - baoquankhu1.vn
Bessemer Group Inc. Purchases Shares of 810,951 AxoGen, Inc. $AXGN - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Brown Capital Management LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 1-Year HighHere's Why - MarketBeat
Y Intercept Hong Kong Ltd Lowers Holdings in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) Is Up 6.2% After Expanding Financing Capacity With Universal Shelf RegistrationHas The Bull Case Changed? - simplywall.st
Why (AXGN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Analyst Upgrade: How does Axogen Inc correlate with Nasdaq2025 Momentum Check & Weekly High Return Opportunities - baoquankhu1.vn
AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 23.5% Revenue Growth and 8.82% Upside Potential - DirectorsTalk Interviews
Axogen Inc (AXGN) Trading Down 2.86% on Jan 28 - GuruFocus
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Viking Therapeutics (VKTX) - The Globe and Mail
Axogen stock hits 52-week high at 34.79 USD By Investing.com - Investing.com Australia
Aug Levels: Is Axogen Inc a play on infrastructure spendingWeekly Trading Summary & Expert Approved Trade Ideas - baoquankhu1.vn
AxoGen (NASDAQ:AXGN) Sets New 52-Week High Following Analyst Upgrade - MarketBeat
Axogen Inc (AXGN) Trading 4.65% Higher on Jan 26 - GuruFocus
Axogen stock hits 52-week high at 34.79 USD - Investing.com
Income Plays: Is DESP on track to beat earningsRate Hike & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Axogen, Inc. (NASDAQ:AXGN) On The Verge Of Breaking Even - 富途牛牛
A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering - Yahoo Finance
Axogen Upsized Equity Raise Shifts Debt Profile And Valuation Focus - Sahm
Is Axogen Inc.’s growth already priced inJuly 2025 Technicals & Fast Entry and Exit Trade Plans - mfd.ru
AxoGen (NASDAQ:AXGN) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Axogen (AXGN) Is Up 5.8% After Upsized Equity Raise and Debt PaydownWhat's Changed - Yahoo Finance
AxoGen Announces Equity Offering to Repay Term Loan - The Globe and Mail
Axogen Signs Underwriting Agreement With Wells Fargo Securities and Mizuho Securities USA - TradingView
Axogen (AXGN) prices stock offering and targets $69.7M term loan payoff - Stock Titan
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Axogen stock dips after pricing $124M offering - MSN
AxoGen (NASDAQ:AXGN) Shares Gap DownTime to Sell? - MarketBeat
Axogen Shares Drop After Pricing $124 Million Stock Offering - marketscreener.com
Axogen plans $85 million stock offering to repay debt By Investing.com - Investing.com Australia
Axogen (AXGN) Increases Stock Offering to $124 Million - GuruFocus
Axogen (AXGN) Shares Decline After Upsized Public Offering - GuruFocus
Axogen prices upsized public offering of common stock at $31 per share - Investing.com Nigeria
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock - The Manila Times
Surgical nerve repair company Axogen prices $124M stock sale to pay off term loan - Stock Titan
Axogen Announces Pricing Of Upsized $124 Million Public Offering Of Common Stock - TradingView
Axogen announces proposed $85M public stock offering; shares down - MSN
AXGN stock rises pre-market after FDA approves nerve repair graft - MSN
Axogen stock falls after $85 million share offering announcement By Investing.com - Investing.com Nigeria
Axogen stock falls after $85 million share offering announcement - Investing.com
Axogen plans $85 million stock offering to repay debt - Investing.com
Surgical device maker Axogen falls on stock offering plans - TradingView — Track All Markets
Axogen Inc Files For Mixed Shelf Offering Size Not Disclosed - TradingView
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):